Ms. Robin Smith Hoke is the President & Chief Executive Officer of Leiters. Prior to joining Leiters, Ms. Hoke served as the Chair of the Board of Directors and Interim Chief Executive Officer at Ricerca Biosciences, a private equity backed pre-clinical CRO.
Ms. Hoke also served as President of GeneraMedix, Inc., a generic and specialty pharmaceutical company serving the acute care market. Prior to GeneraMedix, she served in a variety of executive roles at Cardinal Health, including Senior Vice President of Global Business Development and Strategic Initiatives, Generic Pharmaceuticals, and General Counsel for Cardinal Health's Pharmaceutical Technologies & Services business. She has held legal roles at Abbott Laboratories and as a Partner in the business law firm of Kegler, Brown, Hill & Ritter, Co., L.P.A.
Ms. Hoke currently serves on the Board of Directors of AeroSafe Global, a cold-chain service provider for the bio-pharma industry that results in zero temperature excursions for every client, every product, every time. She previously served on the boards of Aeterna Zentaris, a bio-pharmaceutical company that serves the needs of patients with rare endocrine diseases, and served as an Independent Director for Camargo Pharmaceuticals, LLC., a global 505B2 specialty company.
